LWAC
NVS icon

Laurel Wealth Advisors (California)’s Novartis NVS Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.63M Sell
17,911
-214
-1% -$18K 0.16% 143
2022
Q3 		$1.38M Sell
18,125
-172
-0.9% -$14.3K 0.15% 155
2022
Q2 		$1.55M Sell
18,297
-2,472
-12% -$217K 0.16% 142
2022
Q1 		$1.82M Buy
20,769
+2,023
+11% +$175K 0.15% 148
2021
Q4 		$1.64M Buy
18,746
+623
+3% +$51.7K 0.13% 164
2021
Q3 		$1.48M Buy
18,123
+284
+2% +$25.6K 0.27% 78
2021
Q2 		$1.63M Sell
17,839
-233
-1% -$20.7K 0.21% 113
2021
Q1 		$1.54M Sell
18,072
-718
-4% -$64.4K 0.23% 97
2020
Q4 		$1.77M Sell
18,790
-18
-0.1% -$1.57K 0.26% 90
2020
Q3 		$1.64M Sell
18,808
-867
-4% -$75.1K 0.27% 88
2020
Q2 		$1.72M Buy
19,675
+948
+5% +$81.8K 0.31% 80
2020
Q1 		$1.54M Buy
18,727
+95
+0.5% +$8.48K 0.35% 70
2019
Q4 		$1.76M Sell
18,632
-5
-0% -$449 0.3% 87
2019
Q3 		$1.62M Sell
18,637
-234
-1% -$21K 0.28% 90
2019
Q2 		$1.72M Sell
18,871
-2,189
-10% -$185K 0.38% 64
2019
Q1 		$1.81M Sell
21,060
-455
-2% -$36.5K 0.45% 55
2018
Q4 		$1.65M Sell
21,515
-340
-2% -$26.5K 0.49% 52
2018
Q3 		$1.69M Sell
21,855
-24,617
-53% -$1.82M 0.41% 58
2018
Q2 		$3.14M Buy
46,472
+23,447
+102% +$1.62M 0.84% 25
2018
Q1 		$1.67M Sell
23,025
-344
-1% -$26.2K 0.52% 49
2017
Q4 		$1.76M Buy
23,369
+2,303
+11% +$174K 0.51% 52
2017
Q3 		$1.62M Buy
21,066
+361
+2% +$27.3K 0.54% 49
2017
Q2 		$1.55M Hold
20,705
– – 0.55% 51
2017
Q1 		$1.38M Buy
20,705
+1,509
+8% +$101K 0.53% 54
2016
Q4 		$1.25M Buy
19,196
+4,440
+30% +$288K 0.55% 53
2016
Q3 		$1.04M Sell
14,756
-18
-0.1% -$1.31K 0.49% 62
2016
Q2 		$1.09M Sell
14,774
-168
-1% -$11.6K 0.52% 59
2016
Q1 		$970K Sell
14,942
-1,517
-9% -$103K 0.49% 55
2015
Q4 		$1.27M Buy
+16,459
New +$1.31M 0.66% 41

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Laurel Wealth Advisors (California)'s NVS Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Novartis (NVS) stake by 1.2% in Q4 2022, selling an estimated $18K and leaving 17,911 shares worth $1.63M. The position accounts for 0.16% of the portfolio, ranked #143.

Laurel Wealth Advisors (California) first reported a position in NVS in Q4 2015 and has held it in 29 quarters since. The position peaked at $3.14M in Q2 2018. 1,182 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

  • Laurel Wealth Advisors (California) held 17,911 shares of Novartis worth $1.63M as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 214 Novartis shares in Q4 2022, an estimated $18K.
  • Novartis made up 0.16% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #143 holding.
  • Laurel Wealth Advisors (California) first reported a position in Novartis in Q4 2015 and has held it in 29 quarters since.
  • Laurel Wealth Advisors (California)'s Novartis position peaked at $3.14M in Q2 2018.
  • 1,182 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.